| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.2M | -44.6% |
| Cost of Revenue | $26.4M | -44.0% |
| Gross Profit | -$194K | -298.0% |
| R&D Expense | $229K | -29.8% |
| SG&A Expense | $8.3M | -34.3% |
| Operating Income | -$11.1M | +18.2% |
| Pre-tax Income | -$9.8M | -290.0% |
| Income Tax | -$3K | -101.7% |
| Net Income | -$9.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.4M | -38.8% |
| Accounts Receivable | $1.7M | -49.3% |
| Current Assets | $12.3M | -38.2% |
| Total Assets | $19.7M | -39.8% |
| Current Liabilities | $5.7M | -35.4% |
| Total Liabilities | $7.4M | -32.3% |
| Stockholders' Equity | $12.3M | -43.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | +63.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $552K | +110.1% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$3.2M | +65.2% |
| -255.5% |
| EPS (Basic) | -$1.37 | -226.2% |